Srirangarajan Raju, MD Hospitalist Medicare: Not Enrolled in Medicare Practice Location: 1759 E Villa Dr, Cottonwood, AZ 86326 Phone: 289-235-8835 Fax: 289-226-6411 |
Angie Tu, DO Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 269 S Candy Ln, Cottonwood, AZ 86326 Phone: 510-495-7028 |
Lee M Farmer, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 269 S Candy Ln, Cottonwood, AZ 86326 Phone: 928-639-5588 Fax: 928-639-5589 |
Dr. Joseph Thomas Bergerson, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 269 S Candy Ln, Cottonwood, AZ 86326 Phone: 928-639-5588 Fax: 928-639-5589 |
Kyle Williams, DO Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 269 S Candy Ln, Cottonwood, AZ 86326 Phone: 928-634-2251 |
Dr. Kristina S Kezar, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 269 S Candy Ln, Cottonwood, AZ 86326 Phone: 928-639-5588 Fax: 928-639-5589 |
Aaron Schnell, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 269 S Candy Ln, Cottonwood, AZ 86326 Phone: 928-639-5588 |
News Archive
Regenerative medicine, or the use of specially grown tissues and cells to treat injuries and diseases, has been successful in treating disorders of a number of organs, including heart, pancreas, and cartilage. However, efforts to treat disorders of the corneal endothelium, a single cell layer on the inner surface of the cornea, with regenerative techniques have been less effective. Now, a group of scientists has developed a method that enhances the adhesion of injected corneal endothelial cells (CECs), allowing for successful corneal transplantation to repair pathological dysfunctions.
People with epilepsy have a rare risk of sudden death. A new study shows that risk may apply even to people whose epilepsy is well-controlled, which is contrary to previous, smaller studies that showed the risk was highest among those with severe, difficult-to-treat epilepsy.
HEEL that PAIN is a joint venture between GID Development Corp. and Dr. Art Smuckler, a certified podiatrist. After developing a few customized foot-pads for patients complaining of persistent heel pain, Smuckler wanted to share the benefits of these foot pads with the mass market.
Spacelabs Healthcare has received clearance under Section 510(k) from the U.S. Food and Drug Administration to market Arkon, a high-performance anesthesia delivery system designed from the anesthesiologist's perspective.
News outlets examine how the marketing of medical devices and treatments impacts health care costs and physicians' decisions.
› Verified 4 days ago